| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Genelux Corporation (GNLX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. GNLX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 534.8K | $1.56M | - | |
| Dir | 472.8K | $1.38M | -10,000 | |
| Other | 275.0K | $803.0K | - | |
| Other | 270.0K | $788.4K | - | |
| Other | 155.2K | $453.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 | Yu Yong78 | VP, Clinical Trial Operations | Sale+OE | 6,000 | $27.96 | $167,785.80 | -5.4% | -52.7% | -91.8% | |
| Sep 20, 2023 | Ryder Sean52 | General Counsel | Sale+OE | 10,000 | $30.00 | $300,000.00 | -94.6% | -52.7% | -91.8% | |
| Sep 19, 2023 | Szalay Aladar78 | 10% Owner | Sell | 62,459 | $24.92 | $1,556,591.23 | -74.7% | -53.9% | -91.1% | |
| Sep 18, 2023 | Thomas John77 | Director | Sell | 6,667 | $23.45 | $156,312.65 | -0.5% | -50.2% | -90.0% | |
| Sep 15, 2023 | Yu Yong78 | VP, Clinical Trial Operations | Sale+OE | 10,400 | $21.89 | $227,630.23 | -4.6% | -34.5% | -89.2% | |
| Sep 14, 2023 | Szalay Aladar78 | 10% Owner | Sell | 44,308 | $21.80 | $965,899.28 | -17.5% | -37.6% | -88.9% | |
| Sep 13, 2023 | Yu Yong78 | VP, Clinical Trial Operations | Sell | 29,800 | $21.14 | $629,927.30 | -21.9% | -40.2% | -87.4% | |
| Sep 13, 2023 | Smither John W65 | Director | Sell | 900 | $20.78 | $18,702.00 | -11.5% | -40.2% | -87.4% | |
| Sep 12, 2023 | Szalay Aladar78 | 10% Owner | Sell | 52,616 | $22.23 | $1,169,868.21 | -11.7% | -45.4% | -88.5% | |
| Sep 8, 2023 | Szalay Aladar78 | 10% Owner | Sell | 37,277 | $23.57 | $878,600.01 | -4.9% | -47.0% | -87.7% |